Sun, May 29, 2005 page19

• Stem-cell breakthrough announced

  A Chicago team's efficientnew method of creating stem cells,if confirmed, could dampen ethicalobjections and render South Korea'srecent development obsolete

  • AFP
  • • 
    • 
    • 

  Less than a week after a South Korean team announced a major breakthrough in stem-cell research, American rivals may have already gone one better, the British magazine <> said last week.

  The South Korean technique "could already be obsolete," the British weekly reported, cautioning however that the US claim has yet to be confirmed.

  The South Korean team won high praise but also ignited controversy when they unveiled their method for cloning embryonic stem cells, the primitive "master cells" that are at the forefront of medical research.

  The hope is that, one day, stem cells can be coaxed into growing into specific cells to help replenish dead or damaged tissue in the brain, liver, skin, retina and other organs.

  To overcome rejection by the patient, the goal is to take an embryonic stem-cell and reprogram it using the patient's own DNA -- to make a clone.

  But the cloned cells would not be allowed to grow into a baby. Instead, after a few days, they would be harvested and allowed to develop into duplicating lines of stem cells --

  a key phase in the attempt to get

  them to "differentiate" into specific cells.

  The main achievement of the South Koreans, led by Seoul National University professor Woo Suk Hwang, was the success rate in getting a very high number of cloned stem-cell lines out of the donated eggs used to get the embryo.

  a simpler method

  Now, according to New Scientist, a team headed by Yuri Verlinsky of the Reproductive Genetics Institute in Chicago claims to have made patient-matched human stem cells far more simply and without having to use therapeutic cloning.

  Verlinsky has patented his technique and details of it are sketchy, according to the report, which appeared in yesterday's issue.

  He first removes the programming core, or nucleus, of existing embryonic stem cells, apparently by placing the cells in a centrifuge and spinning them until the denser nucleus is forced out.

  The enucleated egg is then "fused" with cells taken from adults.

  The idea is that the stem cell's cytoplasm -- the part of the cell that is responsible for cell functions -- reprograms the donor nuclei, turning the fused cell into an embryonic stem cell, but one that is genetically identical to the adult donor.

  tentative success

  Verlinsky claims to have created 10 lines of embryonic stem cells using this so-called "stembrid" method.

  But so far he has only outlined his research at a medical conference in London, not submitted it to a peer-reviewed publication, and many experts are skeptical, New Scientist said.

  They demand to see evidence that Verlinsky's "stembrids" are an exact genetic copy of the donor. Even the tiniest genetic flaws could have enormous repercussions.

  "Verlinsky's method would have huge advantages if it really does work," New Scientist said.

  It would bypass the need to acquire large numbers of fresh human eggs for human cloning, a challenge that is both expensive and in some countries impossible on legal grounds.

  And it would also dampen ethical objections, as scientists could use existing lines of embryonic stem cells and not create any more embryos.

  The South Korean announcement unleashed objections from some groups that it marked a dangerous step towards reproductive cloning -- the deliberate creation of duplicate children.
• Most Popular

  • 1

    Taiwan to purchase 28 more HIMARS

  • 2

    Magnitude 5.5 aftershocks possible after 6.2 quake

  • 3

    Taipei tops list of cities with ‘highest staying power’

  • 4

    Tropical Storm Podul strengthens into typhoon

  • 5

    Alcaraz battles as Shelton, Zverev ease through